Sionna Therapeutics, Inc. (SION)
6.03
+0.16
(+2.73%)
USD |
NASDAQ |
Aug 31, 16:00
6.02
-0.01
(-0.17%)
After-Hours: 20:00
Sionna Therapeutics Total Long Term Debt (Quarterly) : 6.692M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.692M |
| March 31, 2026 | 7.055M |
| December 31, 2025 | 7.408M |
| September 30, 2025 | 7.751M |
| June 30, 2025 | 8.069M |
| March 31, 2025 | 8.378M |
| Date | Value |
|---|---|
| December 31, 2024 | 8.677M |
| September 30, 2024 | 8.968M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 9.749M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 1.978B |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Immunic, Inc. | 0.328M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |